FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

Amgen and AstraZeneca's Tezspire showed significant reductions in nasal polyp severity, congestion, and surgery need in CRSwNP patients in the Phase 3 WAYPOINT trial.

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first ...

There's no cure for the common cold, but there are ways to ease symptoms while the cold runs its course. Here's what helps and what to avoid, according to experts.

Spring officially starts on March 20, bringing with it blooming flowers and sunny skies - as well as seasonal illnesses.

The company said its SinuCleanse product tested positive for a contamination of "Staphylococcus aureus," a bacteria that ...

With respiratory illnesses still circulating, this is a reminder why it's essential to follow best practice with this type of product.

Nasal spray options include steroids (e.g. Flonase, Nasacort), which are best for allergies and long-term inflammation but ...